Immunohistochemistry Market Synopsis:<\/p>\n
Immunohistochemistry Market Size Was Valued at USD 2.32 Billion in 2023, and is Projected to Reach USD 3.82 Billion by 2032, Growing at a CAGR of 5.7% from 2024-2032.<\/p>\n
Immunohistochemistry (IHC) is a practical method in the histological laboratory that involves staining of tissues with particular antibodies for the identification of unique antigens in tissues. It is particularly helpful in diagnostic work and subsequent treatment of diseases especially cancer, based on the presence or otherwise of certain biomarkers. The IHC market comprises reagents, software and instruments applied in both research and clinical practice.<\/p>\n
The market for immunohistochemistry has expanded at an impressive growth pattern primarily being driven by rising rate of cancer diagnosed and the developments in the diagnostic tools. Increasing interest in research and an increasing focus on individualized treatment are pushing IHC applications forward. Also, the increase in aging people and the increasing incidence of chronic diseases has increased the need for highly accurate diagnoses even higher. The market is growing due to the incorporation of IHC in drug development and companion diagnostics, which make it significant to current pathology.<\/p>\n
Moreover, the growth in the IHC market depends on the enablement of technology to improve diagnostic outcomes. Through the adoption of automation, and artificial intelligence the work flow in laboratories undertaking IHC has been enhanced and reduced the ambience of slow turn around time and human interferences. This trend is positively influencing the growth of huge investments from private as well as the public sectors to provide a higher end to IHC solutions for the improvement of patients\u2019 health. Besides, strategic relations between pharma and diagnostics companies are believed to catalyze the creation of new IHC assays, which are also going to fuel the market.<\/p>\n
Immunohistochemistry Market Trend Analysis:<\/p>\n
Rise of Companion Diagnostics <\/p>\n
The fact that PD-L1 IHC is a companion diagnostic is changing the direction of the immunohistochemistry market. Over time, companion diagnostic that work with the particular characteristics of the disease are being incorporated in oncology\u2019s practice. The advancement of more targeted therapies demands identification of biomarkers, and IHC is beneficial in visualizing proteins within unidentified sections of tissue samples. With increased calls from the regulatory authorities for the development of companion diagnostics alongside new all therapeutics, the IHC products market is in for significant growth. This trend is not only improving the outcome of treatments for patients but is also helping to grow revenues for providers of IHC technologies.<\/p>\n
Expansion into Emerging Markets<\/p>\n
An increasing demand for outsourced and new healthcare structures in developed markets is viewed as a promising opportunity for the immunohistochemistry market. South Asia and other areas that form part of the Asia-Pacific region and Latin America in particular are spending significantly on their health facilities, measures that are accumulating to improvement of facilities such as laboratories and enhancing patients\u2019 access to sophisticated diagnostic equipment. This shift is to a need to increase the quality of IHC products since healthcare providers are looking for ways to improve diagnosis. These global product markets make it easier for companies that gain entry into the markets to enjoy more opportunities to capture a larger share of the marked than their competitors. Additionally, it can be more easily partnered with local firms to better penetrate and distribute the product, thus quickly moving into these emerging areas.<\/p>\n
Immunohistochemistry Market Segment Analysis:<\/p>\n
Immunohistochemistry Market is Segmented on the basis of Product, Application, End User, and Region <\/p>\n
By Product, Antibodies segment is expected to dominate the market during the forecast period<\/p>\n
The antibodies segment held the largest share of nearly 40.96% in the year 2022 because antibodies are extensively used for diagnosing diseases and testing new drugs. The upsurge in importance of the monoclonal antibodies and all related product thereof comprising Fc-fusion, antibody fragments, and ADC have rendered it as the leading product usage rate. These antibodies are used in a variety of ways including, pathological anatomy, neuropathological and hematopathological.<\/p>\n
By Application, Diagnosties segment expected to held the largest share <\/p>\n
Further based on application, the global market has been divided into diagnostics and research markets. The diagnostics application segment bought the highest proportions of revenues, of over 69.16%, in 2022 and the same segment is expected to continue its dominance over the market till the end of the expected period. Immunohistochemistry (IHC) tests are particularly suitable for the diagnosis of various chronic diseases including cancer, cardiovascular diseases, infectious diseases, diabetes mellitus, autoimmune diseases, and nephrological diseases. Also, the increasing incidence rate of chronic diseases is expected to enhance the diagnostics segment growth.<\/p>\n
Immunohistochemistry Market Regional Insights: <\/p>\n
North America is Expected to Dominate the Market Over the Forecast period <\/p>\n
For the immunohistochemistry in the year 2023, North America market will grow up to 40% of the overall market share. The leadership of the region can be associated with such factors as well-developed healthcare industry, high investment rate in research and development processes, location of leading market participants. The USA has recently experienced an increase in the cases of cancers, thereby creating the need for tests like IHC. Besides, owing to integration of modern technologies and the availability of numerous laboratories, North America has a vast market share. More so, the area\u2019s strong emphasis on patient-specific treatments and companion diagnostic continues to make it a within the leader in the IHC industry.<\/p>\n
The immunohistochemistry product market is mainly fueled by rise in the number of cancer cases and developments in biomarkers. Growth in the number of cases, increased awareness of healthcare professionals about the importance of proper diagnostics and individual approach to treatment also stimulate market growth. However, there are some factors, including high costs of the advanced IHC technologies and scarcity of skilled personnel prevalent in the developing world, which may negatively influence this market growth. However, it can be noted that new research activities and technologies provide an infinite possibility for innovation and an addition to the market. <\/p>\n
Active Key Players in the Immunohistochemistry Market:<\/p>\n
Abcam plc (UK) <\/p>\n
Agilent Technologies (USA)<\/p>\n
Bio-Techne Corporation (USA)<\/p>\n
Cell Signaling Technology (USA)<\/p>\n
Dako (Denmark)<\/p>\n
Fujifilm Wako Pure Chemical Corporation (Japan)<\/p>\n
Johnson & Johnson (USA)<\/p>\n
Leica Biosystems (Germany)<\/p>\n
Merck KGaA (Germany)<\/p>\n
NeoGenomics Laboratories (USA)<\/p>\n
PerkinElmer, Inc. (USA)<\/p>\n
QIAGEN N.V. (Netherlands)<\/p>\n
Roche Diagnostics (Switzerland)<\/p>\n
Sigma-Aldrich (USA)<\/p>\n
Thermo Fisher Scientific (USA)<\/p>\n
Others Active players.<\/p>\n","protected":false},"excerpt":{"rendered":"
Immunohistochemistry (IHC) is a practical method in the histological laboratory that involves staining of tissues with particular antibodies for the identification of unique antigens in tissues. It is particularly helpful in diagnostic work and subsequent treatment of diseases especially cancer, based on the presence or otherwise of certain biomarkers. The IHC market comprises reagents, software and instruments applied in both research and clinical practice.<\/p>\n","protected":false},"featured_media":7602,"template":"","meta":{"_acf_changed":false},"product_brand":[],"product_cat":[194],"product_tag":[],"class_list":["post-10265","product","type-product","status-publish","has-post-thumbnail","product_cat-healthcare-life-sciences","first","instock","virtual","purchasable","product-type-simple"],"acf":[],"yoast_head":"\n